ArticleIBRO neuroscience reports2026
Dengzhanxixin injection for acute ischemic stroke after reperfusion therapy: A double-blind, placebo-controlled, multi-center clinical trial.
Chong Han et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.